NCT04363632已完成不适用
Prospective Analysis of Morbi-mortality of Patients With Cancers in Active Phase of Treatment Suspected or Diagnosed of a SARS-CoV-2 Infection
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 1,231
- 试验地点
- 18
- 主要终点
- Mortality of cancer patients under active anticancer treatment
研究概览
简要总结
National multicentre epidemiological study to describe retrospectively and prospectively the clinical outcomes of patients with a suspected coronavirus infection (either confirmed or not) while receiving a medical treatment for the underlying cancer
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Other
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Confirmed diagnosis of any type of solid or hematologic tumor;
- •Ongoing anticancer treatment (cytotoxic, targeted therapy, immunotherapy or loco regional procedure, including radiotherapy, surgery or interventional radiology procedure) at the time of inclusion or within the last 3 months prior to inclusion (last treatment administration or last loco regional procedure) ;
- •Patient with suspicion of COVID-19 (clinical symptoms of COVID-19 including fever (>38°C) and/or respiratory tract symptoms), either confirmed or not.
- •Note 1: Patients must have underwent diagnostic procedures: diagnostic test (positive or negative) and/or chest imaging. Note 2: Patients will be eligible regardless of the presence of a neutropenia (either febrile or not) ;
- •Patient and/or family did not decline data collection after complete information.
排除标准
- 未提供
结局指标
主要结局
Mortality of cancer patients under active anticancer treatment
时间窗: 28 days after the date of the diagnostic procedure
Mortality rate, defined as the proportion of patients who are dead 28 days after the date of the diagnostic procedure for the 2 cohorts of patients (positive and negative).
次要结局
- Hospitalizations(28 days after the date of the diagnostic procedure)
- Patients' characteristics(At the date of the diagnostic procedure)
- Overall survival(6 months (i.e. at the the time of last patient last visit))
- Death(6 months (i.e. at the the time of last patient last visit))
- Complications(28 days after the date of the diagnostic procedure)
研究者
研究点 (18)
Loading locations...
相似试验
已完成
不适用
This is a Multicenter, Prospective and Retrospective and Descriptive Epidemiology Study in Patients With Chronic Obstructive Pulmonary Disease (COPD) in KoreaCOPDNCT01419379Takeda1,118
已完成
不适用
Epidemiological Study to Identify Prognosis and Predictive Biomarkers for Advanced or Metastatic Renal Cell CarcinomaMetastatic Renal Cell CarcinomaNCT03519542Spanish Oncology Genito-Urinary Group62
Unknown
不适用
An Observational, Prospective Study of Patients With Chondral and/or Osteochondral Defects of the Knee Treated With NAMICChondral DefectOsteochondral DefectNCT03625180Jordi Villalba Modol24
已完成
不适用
Epidemiology Non-cholera Vibrio InfectionsVibrio InfectionsNCT04451707Groupe Hospitalier de la Rochelle Ré Aunis67
已完成
不适用
Study With DapagliflozinDiabetes Mellitus Type 2NCT02971618AstraZeneca929